Intra Cellular Therapies | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
ALKERMES USD 443.75M 333.52M 2024-12
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
J&J USD 13.63B 8.21B 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Prothena USD -59501000 335K 2024-12
RedHill Biopharma USD -1540000 12M 2024-06
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
United Therapeutics USD 423.5M 27M 2025-03



Intra Cellular Therapies L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.